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Abstract: The interplay of guest 
encapsulation and release mechanisms 
in nanoscale metal-organic vehicles and 
its effect on the drug delivery kinetics 
of these materials were investigated via 
a novel multidisciplinary approach. 
Two rationally-designed molecular 
guests were synthesised, which consist 
of a red-fluorescent benzophenoxazine 
dye convalently tethered to a 
coordinating catechol group and a 
protected, non-coordinating catechol 
moiety. This allowed loading of the 
guests into compositionally and 
structurally equivalent coordination 
polymer particles through distinct 
encapsulation mechanisms: 
coordination and mechanical 
entrapment. The two types of particles 
delivered their fluorescent cargo with 
remarkably different kinetic profiles, 
which could be satisfactorily modelled 
considering degradation- and diffusion-
controlled release processes. This 
demonstrates that careful selection of 
the method of guest incorporation into 
coordination polymer nanoparticles 
allows selective tuning of the rate of 
drug delivery from these materials and, 
therefore, of the time window of action 
of the encapsulated therapeutic agents. 
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Introduction 
Coordination polymer particles (CPPs) have recently emerged as a 
novel family of metal-organic materials formed by self-assembly of 
metal ions and polydentate bridging ligands. 1 , 2  Together with 
crystalline metal-organic frameworks (MOFs), CPPs have been 
proposed for a large variety of applications owing to the intrinsic 
versatility of coordination chemistry, which allows the properties of 
the final materials to be rationally tailored by proper choice of 
metals and ligands. 3  Of special interest is the use of CPPs in 
medicine, which is predicted to have a broad impact in the fields of 
bioimaging and drug delivery.4,5,6 Since the pioneering work from 
Mirkin and co-workers in 2005,1 an increasing number of reports 
have indeed described the successful application of nanoscale 
coordination polymer particles to encapsulate and release 
therapeutic agents.6 Nonetheless, the use of CPPs for drug delivery 
is in its fledgling stage. A detailed rationalisation of guest 
encapsulation and release mechanisms is still required to understand 
the drug delivery kinetics of most CPPs and, consequently, to fully 
assess their potential use as nanocarriers for therapeutic purposes. 
While these issues have already been subject of extensive debate for 
biodegradable organic polymer vehicles as drug delivery 
systems,7,8,9 little attention has so far been paid to them in the case 
of the emerging CPP-based materials.  
 Incorporation of the active molecules in coordination polymer 
nanoparticles usually proceeds via two distinct strategies: (1) 
binding of the drug to the polymer framework as a CPP building 
block10,11,12,13,14 and (2) mechanical entrapment of the therapeutic 
agent within the metal-organic matrix. 15 , 16 , 17  Accordingly, drug 
release can take place though different mechanisms, namely slow 
particle degradation via surface erosion, fast diffusion processes 
and/or a combination of both. This scenario can be even more 
intricate if undesired desorption from the particle surface occurs. As 
a result, complex drug delivery profiles are often encountered in 
CPPs that preclude unambiguous elucidation of the relationship 
between encapsulation and release mechanisms.5,16 
 To share more light into this issue, we have envisioned the 
fabrication of morphologically equivalent CPPs bearing a 
fluorescent guest that can be either coordinated to the polymer 
backbone (M1) or physically encapsulated within the particle (M2). 
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These two materials therefore represent excellent benchmark 
systems to comparatively investigate degradation- and diffusion-
controlled drug release processes in CPPs. A schematic 
representation of this approach is shown in Fig. 1. The molecular 
guest of choice for these studies is a red-fluorescent 
benzophenoxazine dye convalently linked to a coordinating catechol 
group, both in its non-protected (1) and protected forms (2). On the 
other side, cobalt nanoparticles with general composition 
[Co(bix)(3,5-dbsq)(3,5-dbcat)] were used as carriers, where bix is a 
flexible bisimidazole bridging ligand and 3,5-dbsq and 3,5-dbcat 
stand for the semiquinonate radical and catecholate forms of the 3,5-
di-tert-butylcatechol.15,16, 18  Although analogous CPPs containing 
Zn2+ ions and bix ligands have already been reported and evaluated 
for drug delivery applications,15,16 the choice of [Co(bix)(3,5-
dbsq)(3,5-dbcat)] nanoparticles is justified by: (1) the high affinity 
of catechol groups to coordinate to cobalt ions, which provided us 
with a simple way to incorporate the fluorescent guest to the 
polymer backbone in M1 without modification of the coordination 
sphere; (2) the well-known optical properties of [Co(3,5-dbsq)(3,5-
dbcat)(N-N)] units, 19  which must result in efficient fluorescence 
quenching of compounds 1 and 2 while they remain in the interior of 
the nanoparticles and, therefore, allow for selective detection of the 
released guest molecules; and (3) the valence tautomerism exhibited 
by [Co(bix)(3,5-dbsq)(3,5-dbcat)] CPPs,18 which can be exploited to 
assess the morphological similarities between M1 and M2. 
 
 
Figure 1. Chemical structures of fluorescent guest compounds 1 and 2, with which M1 
and M2 coordination polymer particles were prepared to investigate degradation- and 
diffusion-controlled release from CPPs. 
Results and Discussion 
Synthesis and characterization of fluorescent guests 1 and 2. 
Scheme 1 shows the synthetic route followed to obtain 1 and 2. 
Briefly, the tert-butylation and subsequent allylic oxidation of 
commercial 2-methoxy-4-methylphenol gave known aldehyde 3 in 
97% yield, 20  which is a common intermediate for both target 
compounds. At this point, synthetic pathways diverged, either 
temporally protecting the hydroxyl groups of the catechol moiety as 
the corresponding methoxymethylethers, foresighting to obtain 
compound 1, or permanently derivatizating them as the methyl 
ethers found in compound 2. Thus, known intermediate 4a was 
obtained from 3 by sequential demethylation with BBr3, and 
protection of the corresponding catechol with 
methoxymethylbromide (90% overall yield).21  Methylation of the 
free hydroxyl of compound 3 gave previously described derivative 
4b (90%).22 
 
Scheme 1. Synthesis of fluorescent guests 1 and 2. (a) t-BuOH, H3PO4, 80 ºC, 10 h; (b) 
Br2, t-BuOH, rt, 4 h; (c) BBr3, CH2Cl2, rt, 3 h; (d) MOMCl, DIPEA, DMAP, CH2Cl2, 
reflux, 24 h; (e) Me2SO4, K2CO3, (n-Bu)4NI, DMF, rt, 15 h; (f) Ph3PCHCN, toluene, 
reflux, 18 h; (g) H2 (2 atm), Pd/C, EtOAc 18 h; (h) LiAlH4, anh THF, addition at 0 ºC, 
then rt, 15 h; (i) 3-(naphthalen-1-ylamino)propanoic acid, EDCI, DIPEA, CH2Cl2, rt, 18 
h; (j) N-ethyl-5-hydroxy-2-methyl-4-nitrosobenzenaminium chloride, HCl, MeOH, 
reflux, 2 h. 
Next synthetic steps are analogous for both target compounds. The 
Wittig reaction between aldehydes 4a and 4b and the stabilized 
phosphorane 2-(triphenylphosphoranylidene) acetonitrile afforded 
the corresponding olefins 5a (96% yield) and 5b (72% yield), as 
mixtures of Z- and E- isomers. Successive hydrogenation of the 
alkene moieties, at high pressure of H2 under Pd/C catalyst, and 
nitriles, with LiAlH4, furnished amines 7a and 7b in 61 and 51% 
overall yields for both reduction reactions, respectively. After this, 
troublesome formation of amides 8a (31% yield) and 8b (35% yield) 
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was achieved by reaction between amines 7a and 7b and 3-
(naphthalen-1-ylamino) propanoic acid, using 1-ethyl-3-(3-dimethyl 
aminopropyl) carbodiimide (EDCI) as coupling agent.23 Compounds 
1 and 2 were finally obtained by reaction between naphthylamines 
8a and 8b and N-ethyl-5-hydroxy-2-methyl-4-
nitrosobenzenaminium chloride in methanol, under acidic catalyst 
and reflux temperature (45% and 35% yield for 1 and 2, 
respectively).24  Importantly, this last step did not only allow the 
benzophenoxazine dye group of both fluorescent guests to be 
constructed, but also concomitant cleavage of the 
methoxymethylethers to eventually obtain compound 1. 
 Once synthesised, the optical properties of compounds 1 and 2 
were investigated in detail. Fig. 2 plots the absorption and 
fluorescence emission spectra of these species in methanol, which 
are mainly governed by the optical transitions corresponding to their 
benzophenoxazine dye unit. As a result, compounds 1 and 2 display 
equivalent absorption (λmax,1=625 nm, λmax,2=626 nm, 
εmax,1=εmax,2=4.8x10
4 M-1 cm-1) and emission bands (λmax,1=643 nm, 
λmax,2=645 nm), which resemble those reported for similar 
derivatives. 25  Importantly, covalent tethering of the 
benzophenoxazine unit to catechol and o-methoxyanisole groups in 
1 and 2 does not quench its inherent emissive behaviour, the 
resulting dyads thus presenting high fluorescence quantum yields 
(Φf,1=0.40, Φf,2=0.41). Together with their long-wavelength 
absorption and emission spectra, this makes compounds 1 and 2 
ideal fluorescent reporters to monitor guest release from CPPs as 
well as particle degradation. 
 
Figure 2. Absorption (solid lines) and fluorescence emission spectra (dashed lines) of 
fluorescent guests 1 (black) and 2 (red). 
Fabrication and characterization of M1 and M2 CPPs. Adapting 
an experimental procedure previously published by us,18 
coordination polymer particles M1 and M2 were prepared by 
reaction of Co2+ ions with the ditopic ligands 1,4-bis(imidazol-1-
ylmethyl)benzene and 3,5-di-tert-butylcatechol in the presence of 
guest compounds 1 and 2 (Fig. 3a). This led to the formation of 
[Co(bix)(3,5-dbsq)(3,5-dbcat)] polymers, which readily precipitated 
as nanoparticles due to their low solubility in the reaction medium. 
The resulting CPPs were subsequently collected by centrifugation, 
washed with 5:1 water:ethanol mixtures until no red fluorescence 
was observed in the supernatant solution, and finally dried. For 
comparison purposes, guest-free coordination polymer nanoparticles 
(M0) were also prepared using this methodology. Noticeably, very 
small amounts of compounds 1 and 2 were used in the preparation 
of materials M1 and M2 (catechol:guest molar ratio ~ 100:1). With 
such low doping loads we intended to minimize the effect of the 
fluorescent guests on the formation of the nanoparticles, which 
should allow us to unambiguously ascribe the differences observed 
in their release profiles to the occurrence of distinct guest 
incorporation and delivery mechanisms. 
 
Figure 3. (a) Schematic synthesis of CPPs doped with fluorescent guests 1 and 2. (b-c) 
SEM (left) and TEM (right) images of M1 (b) and M2 (c) particles. Scale bars for SEM 
are 1 µm and for TEM are 200 nm. 
 Formation of morphologically equivalent CPPs was indeed 
revealed by scanning (SEM) and transmission (TEM) electron 
microscopy images (Fig. 3b-c and see also Fig. S1 in the Supporting 
Information). In all cases nanometer-sized solid particles with 
spherical shapes and rather uniform and similar diameters (195 ± 38, 
152 ± 22 and 185 ± 37 nm for M0, M1 and M2, respectively) were 
obtained. X-ray diffraction experiments confirmed the amorphous 
character of these materials, while spectroscopic characterisation 
upon dissolution of the nanoparticles in degassed methanol revealed 
the occurrence of different electronic absorption bands arising from 
their constituent functional units (Fig. 4a). Thus, an absorption band 
at λ∼625 nm was selectively found in the spectra of M1 and M2, 
which corresponds to the fluorescent benzophenoxazine moiety 
loaded in these materials. On the contrary, the other absorption 
bands at λ∼400, 590 and 700 nm were not only encountered in the 
spectra of M1 and M2, but also observed for guest-free M0. These 
can be ascribed to intraligand and metal-to-ligand/ligand-to-metal 
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charge transfer electronic transitions of the [Co(bix)(3,5-dbsq)(3,5-
dbcat)] system.26 Noticeably, these absorption bands corresponding 
to the coordination complex units expand all over the UV, vis and 
NIR regions, and therefore they overlap with the emission spectrum 
of the benzophenoxazine dye (see Fig. 2a). Consequently, efficient 
quenching of dye fluorescence via resonant energy transfer 
processes is expected in the interior of the nanoparticles, where 
these moieties will be located at the near proximity of coordination 
complex units regardless of whether they are directly coordinated to 
the metal centre or physically encapsulated within the polymer 
network. Indeed, no red fluorescence could be measured for M1 and 
M2 particles in the solid state, which confirms effective quenching 
of the emission of the loaded guests (Fig. 4b). 
 
Figure 4. (a) Absorption spectra of M0 (green), M1 (black) and M2 (red) in degassed 
MeOH. (b) Fluorescence emission spectra recorded in degassed MeOH (dashed lines) 
and non-degassed MeOH (solid lines) of M1 (black) and M2 (red). 
Fluorescence quenching is however inhibited upon guest release 
and CPP degradation, which allowed us to monitor the delivery of 
the particle cargo by means of highly sensitive emission 
measurements (vide infra). This was demonstrated by measuring the 
optical properties of M0, M1 and M2 in non-degassed methanol, 
where particle dissolution is followed by coordination polymer 
degradation via ligand exchange and concomitant oxidation of the 
catecholate and semiquinone groups. This leads to disappearance of 
the absorption bands associated to the [Co(bix)(3,5-dbsq)(3,5-
dbcat)] coordination polymers as well as pronounced growth of the 
band at λ∼400 nm corresponding to the quinone species resulting 
from catecholate and semiquinone degradation (see Fig. S2 in the 
Supporting Information). 27  Accordingly, no energy transfer 
processes are expected under such conditions and an enormous 
increase in benzophenoxazine emission was indeed measured (Fig. 
4b). The absorption measurements in non-degassed methanol were 
also used to quantify the encapsulation efficiencies for the 
preparation of dye-doped M1 and M2 particles. Interestingly, higher 
values were obtained for M1 (∼20%) than for M2 (∼10%) under 
equivalent experimental conditions, which indicates that 
incorporation of the fluorescent guest bearing a coordinating 
catechol moiety is significantly more effective.  
Valence tautomerism of M1 and M2 CPPs. The amorphous nature 
of M1 and M2 nanoparticles precludes any accurate structural 
characterisation by classical diffraction techniques. Nevertheless, we 
exploited the valence tautomerism (VT) behaviour shown by 
[Co(bix)(3,5-dbsq)(3,5-dbcat)] CPPs18,19 to investigate the structural 
similarities between M1 and M2. These systems might interconvert 
reversibly between the low-spin ls-[CoIII(bix)(3,5-dbsq)(3,5-dbcat)] 
and high-spin hs-[CoII(bix)(3,5-dbsq)2] tautomers by intramolecular 
metal-ligand electron transfer, a process that can be selectively 
monitored by temperature dependent measurements of magnetic 
susceptibility.  
Fig. 5 plots the results obtained in those measurements for M0, 
M1 and M2. In all cases, an abrupt change in effective magnetic 
moment (µeff) is observed around 300 K, which is consistent with 
valence-tautomeric interconversion from low- to high-spin states for 
a large fraction of molecules in the nanoparticles.18 Importantly, the 
occurrence of valence tautomerism and the actual profile of the 
corresponding µeff vs T plot is not only highly sensitive to metal 
complex composition and structure, but also to the local 
environment.19 In other words, the same complex may exhibit or not 
VT, or the low-spin-to-high-spin conversion might take place at 
different temperatures depending on structural and environmental 
parameters. Therefore, the extremely similar magnetic behaviour 
encountered for M0, M1 and M2 clearly indicates that they must be 
formed by equivalent coordination polymers in rather comparable 
phases. 
  
Figure 5. µeff values as function of temperature for M0 (green), M1 (black) and M2 
(red) CPPs. 
Guest release mechanisms. To investigate guest release from M1 
and M2, colloidal suspensions were prepared in phosphate buffered 
saline solutions (PBS) at pH=7.4, placed in a dialysis bag (cut-off 
molecular weight: 3500 Da) at 37ºC, and finally dialysed against 
PBS for 100 hours. Relative cumulative release profiles were then 
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measured by monitoring the fluorescence of the dialysis bath 
solution in time. In addition, the solid material remaining in the 
dialysis bag after 100 hours was dissolved in methanol and 
characterised by absorption spectroscopy, which allowed us to 
determine the absolute release efficiency of the dialysis experiment. 
Fig. 6 plots the cumulative release profiles measured for M1 and 
M2 under these experimental conditions. Both exhibit very high 
release efficiencies after 100 hours (~90%) with no “burst effects” 
associated to undesired desorption of guest molecules physisorbed 
onto the nanoparticle surface. However, the release kinetics 
measured for these materials were found to be strikingly different. 
In the case of M2, the delivery process was nearly completed after 8 
h (t1/2 ~1.2 h), a behaviour resembling that already reported for the 
release of anticancer drugs mechanically entrapped in analogue 
[Zn(bix)] CPPs.16 In contrast, a much slower process was observed 
for M1, which required about 100 h for completion (t1/2 ~11 h). 
 
Figure 6. Guest release profiles of fluorescent guest molecules from M1 (black) and M2 
(red) at 37 ºC, which were averaged over 4 independent experiments. Solid lines 
correspond to fits of the experimental data as described in the text. 
 On the basis of the non-coordinating nature of the encapsulated 
guest, the release profile of M2 at 37ºC was fitted with a purely 
diffusion-controlled model of drug delivery. In particular, we 
considered the use of equation (1), which was derived for drug 
delivery via Fickian diffusion from spherical particles with 
homogenous and low-doping loads that do not significantly swell or 
degrade during the release process:28 
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In this equation, Mt and M∞ represent the cumulative absolute 
amounts of guest released at time t and infinity, R is the radius of the 
particles and D is the apparent diffusion constant of the drug within 
the system. D is the only variable parameter in this model, which is 
taken to remain constant throughout the release process by 
neglecting swelling and degradation effects on the structure of the 
polymeric drug carrier. 
 As observed in Fig. 6, a rather satisfactory fit of the experimental 
release kinetics of M2 was obtained using equation (1). Therefore, 
the delivery of the mechanically-entrapped fluorescent guest must 
be governed by a time-independent diffusion mechanism (D = 
6.9x10-19 m2 s-1), which indicates that the influence of degradation 
processes on the release kinetics is negligible in this case even 
though it takes place. This is proven by Fig. 7, which displays SEM 
images of M2 nanoparticles suspended in aqueous media at 37ºC for 
0, 5, 26 and 100 h. While most particles preserved their spherical 
shape after 5 h, extensive surface erosion and an increasing amount 
of non-structured material is observed in the SEM images registered 
at 26 and 100 h. This confirms CPP degradation, which however 
takes place at a longer time scale than guest diffusion from the 
nanoparticles at 37ºC. This is in contrast with other systems for 
which clearly different delivery phases are observed that are 
ascribed to the occurrence of sequential fast diffusion and slow 
degradation processes.7-9 
 
Figure 7. SEM images of M2 CPPs suspended at 37 ºC in aqueous media for (a) 0 h, (b) 
5 h, (c) 26 h and (d) 100 h. Scale bars are 500 nm. 
 The release profile obtained for M1 at 37ºC was also tentatively 
fitted with single-mechanism models, which in this case should 
solely account for degradation-controlled delivery. However, poor 
agreement between the experimental and fitted release profiles was 
obtained regardless of using surface-degradation 29  or bulk-
degradation30 models of drug delivery. This suggests the occurrence 
of a more complex release process, which we attempted to model by 
assuming simultaneous delivery via degradation and diffusion 
processes. In this scenario, degradation-controlled release should 
apply for all guest molecules coordinated to the polymeric 
backbone, while those that remain unbound but physically entrapped 
within the metal-organic matrix should be preferentially delivered 
by fast diffusion processes. Based on the previous results obtained 
for M2 and analogue [Zn(bix)] CPPs,16 equation (2) was derived to 
account for such situation: 
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The first term in this equation corresponds to the Fickian 
diffusion model already applied to M2, where b is the fraction of 
guest molecules that lie mechanically entrapped within M1 particles. 
As previously discussed, this model assumes that the diffusion-
controlled release of guest molecules takes place before significant 
degradation of the polymer matrix occurs, which allows the particle 
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radius and the apparent guest diffusion constant to be considered 
time independent. This assumption is not only supported by the 
behaviour observed for M2, but also by the similar results obtained 
when monitoring the degradation process of M1 nanoparticles at 
37ºC in water media using SEM (see Fig. S3 in the Supporting 
Information). The second term in equation (2) corresponds to an 
empirical model that has been developed for degradation-controlled 
drug delivery from spherical particles via surface erosion,29 which is 
indeed the degradation mechanism reported for analogue [Zn(bix)] 
CPPs at physiological conditions.16 In this expression (1-b) is the 
fraction of guest molecules coordinated to the metal centres in M1, 
kd is the surface erosion rate constant, C0 is the total initial 
concentration of the guest in the polymer matrix (7.2x10-4 % (w/w)) 
and R is the initial radius of the nanoparticles. 
 To fit equation (2) to the guest release profile measured for M1 at 
37ºC, only two variable parameters were considered: b and kd. To 
test the consistency of our model, D was directly taken from the 
previous fit of M2 delivery kinetics, a rather plausible constraint 
based on the very similar structures of the guest compounds and 
coordination polymer particles investigated in this work. As 
observed in Fig. 6, a good agreement was encountered between the 
experimental and fitted release profiles of M1 even under such 
assumption, which proves the validity of our treatment (b = 0.26, kd 
/(C0 R)=
 1.7x10-6 s-1). From this we conclude that most guest 
molecules in M1 nanoparticles (74%) are directly bound to the 
polymer matrix, which are therefore released by slow degradation of 
the material. Nevertheless, a significant fraction of them (26%) are 
not coordinated to cobalt ions despite presenting free catechol 
groups, but they were physically encapsulated during the formation 
of the particles. Accordingly, they are delivered via a fast time-
independent diffusion mechanism similar to that encountered for 
M2 CPPs. 
 Additional guest release experiments were performed at 60ºC 
aiming at investigating the temperature dependence of the delivery 
processes in these materials (see Fig. S4 in the Supporting 
Information). In deep contrast to what had been observed at 37ºC, 
no significant differences were found between the release profiles 
measured for M1 and M2 at this temperature. In both cases, 
complete delivery of the fluorescence guests is observed at ∼5 h, 
revealing the occurrence of much faster release processes. This 
suggests that degradation kinetics enormously accelerates at 60ºC, 
which must become at least comparable to guest diffusion rates. As 
a matter of fact, we expect the release profiles of M1 and M2 CPPs 
at these conditions to be mainly governed by degradation processes, 
which indicates that both the guest delivery kinetics and 
mechanisms of these materials can be dramatically altered by 
temperature control. 
Conclusion 
In this work we report a novel rational approach to investigate the 
relationship between guest encapsulation and release mechanisms 
for metal-organic nanoparticles. By proper design of the guest 
compounds and particle formation conditions, two types of 
coordination polymer particles were prepared that (1) are 
compositionally and structurally equivalent, and (2) were loaded 
with the same fluorescent guests using different encapsulation 
processes. As a result, the release of their fluorescent cargo at 
physiological conditions proceeds via distinct mechanisms that 
converge upon increasing the temperature. Physically encapsulated 
guest molecules are delivered by fast time-independent diffusion 
processes, while the release of coordinated guest moieties is 
governed by slow particle degradation. This leads to remarkably 
different guest release profiles for the CPPs prepared, which 
demonstrates that the kinetics of drug delivery can be selectively 
tuned up to many hours by appropriate choice of the mechanism of 
incorporation of the therapeutic agent into the polymeric nanocarrier. 
This results open new venues for the future use of CPPs in medicine. 
Experimental Section 
Materials and characterisation: All reactants and reagents were purchased from 
Sigma-Aldrich and used as received. Solvents were purchased from Scharlab and used 
as received. Dialysis bags were purchased from Orange Scientific.Infrared spectra were 
recorded on a Bruker Tensor 27 spectrometer equipped with a Golden Gate Single 
Reflection Diamond ATR (Attenuated Total Reflectance) accessory. High resolution 
mass analyses were performed on an ESI-QTOF Bruker Daltonics micrOTOF-Q 
spectrometer. NMR spectra were recorded on a Bruker ARX 400 (400 MHz for 1H 
NMR and 100 MHz for 13C NMR). The spectra are given in δ (ppm) using the signal of 
the residual non-deuterated solvent molecules as reference. Absorption spectra were 
recorded on a Hewlett Packard 8453 spectrophotometer. HPLC or spectroscopy quality 
solvents were used. Emission spectra were measured by means of a custom-made 
spectrofluorimeter, where a cw He-Ne REO laser (λexc = 594 nm) was used as excitation 
source and the emitted photons were detected in an Andor ICCD camera coupled to a 
spectrograph. HPLC or spectroscopy quality solvents were used. Fluorescence quantum 
yields were determined using Nile Blue A in ethanol solution as reference (Φf =0.27).
31 
SEM measurements were registered on a HITACHI S-570 microscope (accelerating 
voltage 0.5–30 kV). TEM measurements were carried out on a HITACHI-7000 
microscope operating at 125 kV. 
Synthesis of compound 4a: This compound was prepared according to ref. [21] with 
some modifications. Demethylation: To a solution of 3 (0.845 g, 4 mmol) in CH2Cl2 (30 
mL) cooled down in a liquid nitrogen bath, 4 mL of 1 M solution of BBr3 in CH2Cl2 
were added dropwise. Next, the reaction was allowed to proceed at room temperature 
for 2 h. The reaction mixture was poured in 40 ml distilled water and the resulting 
aqueous layer was extracted twice with CH2Cl2 (30 mL). The organic extracts were 
dried with MgSO4 and the solvent evaporated under vacuum to afford the demethylated 
compound as a yellowish solid (0.698 g, 90 %). This compound was used in the next 
step without further purification. Protection of the catechol: To a solution of this 
intermediate (0.492 g, 2.54 mmol) in CH2Cl2 (8 mL) cooled down in a water bath, the 
following compounds were added dropwise: DIPEA (2.7 mL, 15.5 mmol), DMAP (30 
mg, 0.22 mmol) and methoxymethyl bromide (0.65 mL, 8.02 mmol). The solution was 
heated under reflux for 8 h. The reaction mixture was treated with water (15 mL) and 
the resulting aqueous layer was extracted twice with CH2Cl2 (15 mL). The organic 
extracts were dried with MgSO4 and the solvent evaporated under vacuum. Crude was 
purified by flash chromatography using hexanes and ethyl acetate (4:1, v/v) to afford 4a 
(0.716 g, 100 %) as a yellowish oil. 1H RMN (400 MHz, CDCl3): δ  = 9.87 (s, 1H), 7.55 
(s, 2H), 5.31 (s, 2H), 5.23 (s, 2H), 3.66 (s, 3H), 3.52 (s, 3H), 1.45 ppm (s, 9H). 13C 
RMN (100 MHz, CDCl3): δ = 191.5, 151.9, 150.4, 144.0, 131.5, 123.8, 114.5, 99.4, 
95.4, 57.9, 56.6, 35.4, 30.3 ppm. IR (ATR): ν = 3076.2, 2953.3, 2905.4, 2826.8, 1690.1, 
1578.5 cm-1. HRMS (ESI-QTOF): m/z calcd for C15H22NaO5: 305.1359; found: 
305.1356.  
Synthesis of 4b: This compound was prepared according to ref. [22] with some 
modifications. To a solution of 3 (3.5 g, 16.8 mmol) in DMF (100 mL), K2CO3 (6.95 g, 
50.4 mmol) and N,N,N-tributyl-1-butanaminium iodide (270 mg, 0.73 mmol) were 
added. The reaction mixture was stirred for 2 h at room temperature. After this time, 
Me2SO4 (3.2 mL, 33.6 mmol) was added dropwise and the mixture was allowed to react 
for 16 h. The resulting mixture was treated with water (100 mL) and the aqueous layer 
was extracted four times with EtOAc (50 mL). The organic extracts were dried with 
MgSO4 and the solvent evaporated under vacuum to afford 4b (3.36 g, 90 %) as a dark 
green oil. 1H RMN (400 MHz, CDCl3): δ  = 9.91 (s, 1H), 7.48 (d, J = 1.9 Hz, 1H), 7.38 
(d, J = 1.9 Hz, 1H), 3.97 (s, 3H), 3.94 (s, 3H), 1.44 ppm (s, 9H). 
Synthesis of 5a. To a solution of 4a (1.559 g, 5.53 mmol) in toluene (45 mL), 
(triphenylphosphoranylidene)acetonitrile (2.070 g, 6.87 mmol) was added. The reaction 
mixture was heated under reflux for 12h, after which the solvent was evaporated under 
vacuum and the residue was purified by flash chromatography using hexanes and ethyl 
acetate (6:1, v/v) to afford a mixture of (E)- and (Z)-5a (1.621 g, 96 %) as a brown oil 
with a diastereomeric ratio of 2.3:1. 1H RMN (400 MHz, CDCl3): δ  = 7.57 (d, J = 2.2 
Hz, 1H), 7.47 (d, J = 2.2 Hz, 1H), 7.32 (d, J = 16.6 Hz, 1H), 7.16 (d, J = 2.2 Hz, 1H), 
7.06 (d, J = 2.2 Hz, 1H), 7.03 (d, J = 12.0 Hz, 1H), 5.75 (d, J = 16.6 Hz, 1H), 5.34 (d, J 
= 12.0 Hz, 1H), 5.26 (s, 2H), 5.24 (s, 2H), 5.21 (s, 2H), 5.19 (s, 2H), 3.66 (s, 3H), 3.65 
(s, 3H), 3.53 (s, 3H), 3.51 (s, 3H), 1.43 (s, 9H), 1.41 ppm (s, 9H). 13C RMN (100 MHz, 
CDCl3): δ  = 150.7, 150.5, 150.0 148.9, 148.7, 148.6, 143.9, 143.8, 128.6, 128.5, 122.5, 
121.0, 118.6, 117.9, 115.0 , 112.5, 99.3, 99.3, 95.5, 95.4, 94.8, 93.4, 57.9, 57.9, 56.5, 
56.6, 35.5, 35.3, 30.4, 30.3 ppm. IR (ATR): ν = 3371.2, 2953.8, 2213.6, 1615.5, 1428.9 
cm-1. HRMS (ESI-QTOF): m/z calcd for C15H22NaO5: 328.1519; found: 328.1519. 
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Synthesis of 5b. Synthesised from 4b using the same procedure as for 5a. Yield = 72 % 
with a diastereomeric (E):(Z) ratio of 4.8:1. 1H RMN (400 MHz, CDCl3): δ  = 7.53 (d, J 
= 2.1 Hz, 1H), 7.34 (d, J = 16.5 Hz, 1H), 7.23 (d, J = 2.1 Hz, 1H), 7.05 (d, J = 12.1 Hz, 
1H), 7.00 (d, J = 2.0 Hz, 1H), 6.88 (d, J = 2.0 Hz, 1H), 5.75 (d, J = 16.5 Hz, 1H, 4.39 (d, 
J = 12.1 Hz, 1H), 3.92 (s, 3H), 3.92 (s, 3H), 3.90 (s, 3H), 3.88 (s, 3H), 1.39 (s, 9H), 1.37 
ppm (s, 9H). 13C NMR (100 MHz, CDCl3) δ  = 153.7, 153.4, 151.7, 151.2, 151.0, 149.2, 
144.1, 143.7, 128.5, 128.4, 122.0, 119.9, 119.8, 118.6, 110.2, 108.6, 94.5, 92.9, 60.7, 
60.7, 56.0, 56.0, 35.3, 35.3, 30.4, 30.4 ppm. IR (ATR): ν = 2952.0, 2213.3, 1615.6, 
1571.5, 1415.0, 1142.9, 1067.0, 1023.7 cm-1. HRMS (ESI-QTOF): m/z calcd for 
C15H19NaNO2: 268.1308, found: 268.1309. 
Synthesis of 6a. A mixture of (E)- and (Z)-5a (1.442 g, 4.8 mmol) and 10% Pd/C (5:1, 
substrate/catalyst) in ethyl acetate (16 mL) was stirred at room temperature under 
hydrogen atmosphere for 24 h. Next, Pd/C was filtered off and the solvent was removed 
in vacuo. The residue was purified by flash chromatography using hexanes and ethyl 
acetate (3:1, v/v) to afford 6a (1.003 g, 68 %) as a brown oil. 1H RMN (400 MHz, 
CDCl3): δ  = 6.90 (d, J  = 2.1 Hz, 1H), 6.84 (d, J  = 2.1 Hz, 1H), 5.18 (s, 2H), 5.16 (s, 
2H), 3.64 (s, 3H), 3.51 (s, 3H), 2.88 (t, J  = 7.4 Hz, 2H), 2.58 (t, J = 7.4 Hz, 2H), 1.41 
ppm (s, 9H). 13C RMN (100 MHz, CDCl3): δ 150.6, 145.0, 143.9, 133.0, 120.6, 119.2, 
114.7, 99.1, 95.6, 57.6, 56.4 , 35.3, 31.7, 30.6, 19.6 ppm. IR (ATR): ν = 2952.2, 2904.6, 
2826.2, 2374.0, 1602.7, 1433.6, 1154.6, 936.8 cm-1. HRMS (ESI-QTOF): m/z calcd for 
C17H25NaNO4: 330.1376; found: 330.1375. 
Synthesis of 6b. Synthesised from 5b using the same procedure as for 6a. Yield = 67 %. 
1H RMN (400 MHz, CDCl3): δ  = 6.74 (d, J  = 2.1 Hz, 1H), 6.69 (d, J = 2.1 Hz, 1H), 
3.86 (s, 6H), 2.90 (t, J = 7.4 Hz, 2H), 2.60 (t, J = 7.4 Hz, 2H), 1.37 ppm (s, 9H). 
13C 
RMN (100 MHz, CDCl3): δ  = 171.5, 153.7, 148.0, 144.0, 133.0, 119.7, 119.0, 111.0, 
60.8, 56.0, 35.0, 32.2, 30.9 ppm. IR (ATR): ν = 2951.4, 2866.4, 2831.8, 2245.0, 1688.2, 
1580.1, 1421.9, 1346.7, 1260.0, 1067.6, 1006.1 cm-1. HRMS (ESI-QTOF): m/z calcd for 
C15H21NaNO2: 270.1465; found: 270.1465.  
Synthesis of 7a. To a suspension of LiAlH4 (298 mg, 7.9 mmol) in anhydrous Et2O (2 
mL) cooled down in a water bath, a solution of 6a (695 mg, 2.2 mmol) in anhydrous 
Et2O (2 mL) was added dropwise. Next, the reaction mixture was stirred at room 
temperature for 14h under inert atmosphere. The reaction mixture was cooled down to 0 
ºC and quenched with NaOH 1M (15 mL). The resulting aqueous layer was extracted 
with Et2O (15 mL) and CHCl3 (15 mL). The combined organic extracts were dried with 
MgSO4 and the solvent removed in vacuo to afford 7a (627 mg, 89 %) as a yellowish oil. 
This product was used without further purification. 1H RMN (400 MHz, CDCl3): δ  = 
6.85 (d, J  = 2.0 Hz, 1H), 6.80 (d, J  = 2.0 Hz, 1H), 5.17 (s, 2H), 5.16 (s, 2H), 3.64 (s, 
3H), 3.50 (s, 3H), 2.73 (t, J = 7.6 Hz, 2H), 2.58 (t, J = 7.6 Hz, 2H), 1.74 (qt, J = 7.6 Hz, 
2H), 1.40 ppm (s, 9H). 13C RMN (100 MHz, CDCl3): δ  = 150.2, 143.9, 143.3, 137.2, 
120.6, 114.7, 99.1, 95.5, 57.6, 56.4, 42.1, 35.7, 35.2, 33.4, 30.7 ppm. IR (ATR): ν = 
3362.8, 2949.4, 1578.6, 1431.9, 1076.7, 961.7 cm-1. HRMS (ESI-QTOF): m/z calcd for 
C17H29NNaO4: 334.1989; found: 334.1979. 
Synthesis of 7b. Synthesised from 6b using the same procedure as for 7a. Yield = 76 %. 
1H RMN (400 MHz, MeOD-d4): δ  = 6.74 (d, J  = 2.0 Hz, 2H), 3.82 (s, 3H), 3.80 (s, 3H), 
2.70 (t, J = 7.5 Hz, 2H), 2.58 (t, J = 7.5 Hz, 2H), 1.79 (qt, J = 7.5 Hz, 2H), 1.34 ppm (s, 
9H). 13C RMN (100 MHz, MeOD-d4): δ  = 153.5, 146.9, 142.7, 136.8, 118.7, 111.3, 
59.8, 55.3, 40.8, 34.8, 33.9, 33.3, 30.2 ppm. IR (ATR): ν = 3452.3, 2936.2, 1578.1, 
1421.9, 1321.1, 1262.1, 1144.8, 1066.5, 1008.1 cm-1. HRMS (ESI-QTOF): m/z calcd for 
C15H25NNaO2: 252.1958; found: 252.1963. 
Synthesis of 8a. To a solution of 3-(naphthalen-1-ylamino)propanoic acid (646 mg, 3 
mmol), HOBt (589 mg, 4.3 mmol), EDCI (760 mg, 3.9 mmol) and DIPEA (1.6 mL, 9.1 
mmol) in 20 mL of anhydrous CH2Cl2, a solution of 7a (956 mg, 3 mmol) in 10 mL of 
anhydrous CH2Cl2 was added. The reaction mixture was stirred at room temperature for 
17h. Then, it was washed twice with a solution of saturated NaHCO3 (10 mL) and once 
with a solution of saturated NaCl (10 mL). The organic layer was dried with MgSO4 and 
solvent was evaporated under vacuum. Crude was purified by flash chromatography 
using hexanes and ethyl acetate (1:1, v/v) to afford 8a (482 mg, 31 %) as a brown oil. 
1H RMN (400 MHz, CDCl3): δ = 7.81 (d, J = 8.1 Hz, 1H), 7.74 (d, J = 7.6 Hz, 1H), 
7.38 – 7.23 (m, 4H), 6.79 (d, J = 1.9 Hz, 1H), 6.4 (d, J = 1.9 Hz, 1H), 6.58 (d, J = 7.6 
Hz, 1H), 6.04 (s, 1H), 5.16 (s, 2H), 5.11 (s, 2H), 3.63 (s, 3H), 3.54 (t, J = 6.02 Hz, 2H), 
3.46 (s, 3H), 3.24 (dd, J = 13.1 Hz, J = 6.7 Hz, 2H), 2.50 (m, 4H), 1.73 (qt, J = 7.6 Hz, 
2H), 1.39 ppm (s, 9H). 13C RMN (100 MHz, CDCl3): δ 171.9, 150.1, 143.4, 143.1, 
136.23, 134.4, 128.6, 126.5, 125.9, 124.9, 123.9, 120.4, 117.8, 114.5, 104.5, 99.0, 95.4, 
57.6, 56.4, 40.4, 39.3, 35.3, 35.2, 33.3, 31.2, 30.7 ppm. IR (ATR): ν = 3304.4, 2949.4, 
1638.2, 1580.4, 1526.7, 1199.4, 1035.5, 961.9 cm-1. HRMS (ESI-QTOF): m/z calcd for 
C30H40N2NaO5: 531.2829; found: 531.2834.  
Synthesis of 8b: Synthesised from 7b using the same procedure as for 8a. Yield = 35 %. 
1H RMN (400 MHz, MeOD-d4): δ = 7.93 (d, J = 8.1 Hz, 1H), 7.69 (d, J = 7.9 Hz, 1H), 
7.41 – 7.23 (m, 3H), 7.14 (d, J = 8.1 Hz, 1H), 6.69 (d, J = 2.9 Hz, 1H), 6.69 (s, J = 2.9 
Hz, 1H), 6.65 (s, 1 H), 6.60 (d, J = 4.3 Hz, 2H), 3.76 (s, 3H), 3.69 (s, 3H), 3.54 (t, J = 
6.60 Hz, 2H), 3.17 (t, J = 7.00 Hz, 3H), 2.59 (t, J = 6.60 Hz, 2H), 2.53 – 2.45 (m, 4H), 
1.73 (qt, J = 7.6 Hz, 2H), 1.31 ppm (s, 9H). 
13C RMN (101 MHz, MeOD-d4): δ 174.6, 
154.3, 147.7, 144.7, 143.5, 137.6, 135.8, 129.3, 127.6, 126.6, 125.4, 125.1, 121.7, 119.5, 
118.1, 112.1, 105.1, 60.7, 56.1, 41.6, 40.0, 36.3, 35.8, 34.2, 32.3, 31.1 ppm. IR (ATR): 
ν = 2919.5, 2478.6, 2065.58, 1627.1, 1577.7, 1450.4, 1420.8, 1143.8, 1067.9 cm-1. 
HRMS (ESI-QTOF): m/z calcd for C28H36N2NaO3: 449.2799; found: 449.2804.  
Synthesis of 1. To a solution of N-ethyl-5-hydroxy-2-methyl-4-nitrosobenzenaminium 
chloride (72 mg, 0.4 mmol) in 1 mL of MeOH cooled down in a water bath and under 
inert atmosphere, a solution of 8a (170 mg, 0.33 mmol) in 1 mL of degassed MeOH and 
a 3 droplets of HCl 35 % were added. This mixture was heated under reflux for 1.5 h. 
Then it was cold down to room temperature and CH2Cl2 (5 mL) and a mixture of 
saturated NaCl (2 mL) and 3 droplets of HCl 35 % were added. The resulting organic 
layer was washed twice with saturated NaHCO3 (3 mL) and once with saturated NaCl (3 
mL). Next, it was dried with MgSO4 and solvent was removed in vacuo. Crude was 
purified by flash chromatography using CH2Cl2 and MeOH (10:1, v/v) to afford 1 (87 
mg, 45 %) as a bluish-violet solid. 1H RMN (400 MHz, MeOD-d4): δ = 8.73 (d, J = 8.1 
Hz, 1H), 8.22 (d, J = 8.1 Hz, 1H), 7.82 (t, J = 7.5 Hz, 1H), 7.71 (t, J = 7.5 Hz, 1H), 
7.51 (s, 1H), 6.90 (s, 1H), 6.70 (s, 1H), 6.40 (s, 1H), 6.38 (s, 1H), 3.95 (t, J = 6.2 Hz, 
2H), 3.49 (q, J = 7.2 Hz, 3H), 3.21 (m , 2H), 2.75 (t, J = 6.2 Hz, 2H), 2.35 (m, 2H), 2.29 
(s, 3H), 1.67 (qt, J = 7.2 Hz, 2H), 1.46 ppm (s, 9H). 
13C RMN (100 MHz, MeOD-d4): δ 
= 172.9 158.2, 156.9, 152.5, 149.3, 145.7, 143.3, 136.8, 133.9, 132.9, 132.6, 132.5, 
132.4, 132.3, 130.7, 129.0, 125.5, 124.5, 123.6, 118.2, 113.5, 94.5, 94.1, 41.9, 40.3, 
39.8, 35.8, 34.0, 32.5, 30.1, 17.8, 14.2 ppm. IR (ATR): ν = 3213.7, 3076.2, 2921.8, 
2852.5, 1640.1, 1587.6, 1540.9, 1433.8, 1307.7, 1160.8 cm-1. HRMS (ESI-QTOF): m/z 
calcd for C35H41N4O4
+: 581.3122; found: 581.3124. 
Synthesis of 2. Synthesised from 8b using the same procedure as for 1. Yield = 35 %. 
1H RMN (250 MHz, MeOD-d4): δ 8.70 (d, J = 8.1 Hz, 1H), 8.20 (d, J = 8.1 Hz, 1H), 
7.81 (t, J = 7.6 Hz, 1H), 7.70 (t, J = 7.6 Hz, 1H), 7.48 (s, 1H), 6.91 (s, 1H), 6.70 (s, 1H), 
6.51 (s, 1H), 6.49 (s, 1H), 4.56 (s, 2H), 3.97 (t, J = 5.9 Hz, 2H), 3.74 (s , 3H), 3.70 (s , 
3H), 3.49 (q, J = 6.2 Hz, 2H), 3.22 (t, 2H, J = 6.8 Hz, 2H), 2.77 (t, J = 5.9 Hz, 2H), 
2.39 (t, J= 6.8 Hz, 2H), 2.28 (s, 3H), 1.68 (qt, J = 6.8 Hz, 2H), 1.43 – 1.23 ppm (m, 
12H). 13C RMN (63 MHz, MeOD-d4): δ 173.0, 158.2, 156.8, 154.3, 152.5, 149.2, 147.8, 
143.6, 140.2, 137.4, 133.9, 132.9, 132.6, 132.2, 130.7, 129.0, 125.5, 124.5, 123.6, 119.4, 
114.7, 112.1, 94.5, 60.7, 56.2, 41.9, 40.2, 39.8, 35.7, 34.9, 34.2, 33.0, 32.4, 31.9, 31.1 
ppm. IR (ATR): ν = 2920.8, 2851.6, 1640.4, 1588.12, 1541.4, 1451.0, 1310.0, 1160.9, 
1133.6, 1006.6 cm-1. HRMS (ESI-QTOF): m/z calcd for C37H44N4NaO4: 609.3435; 
found: 609.3435.  
Synthesis of M0. To a solution of di-tert-buthylcathecol (107.2 mg, 0.48 mmol) and 
1,4-bis(imidazol-1-ylmethyl)benzene (59.6 mg, 0.25 mmol) in EtOH (5 mL), 1 mL of 
an aqueous solution of Co(CH3COO)2·4H2O (61.7 mg, 0.24 mmol) was added dropwise. 
The mixture was stirred for 10 min and then the formation of nanoparticles was induced 
by fast addition of 25 mL of miliQ H2O. Ligand excess was removed by centrifugation 
and the nanoparticles were washed three times with H2O. 
Synthesis of M1. To a solution of 1 (5.5 mg, 9.5 µmol), di-tert-buthylcathecol (211.5 
mg, 0.95 mmol) and 1,4-bis(imidazol-1-ylmethyl)benzene (117.3 mg, 0.49 mmol) in 
EtOH (20 mL), 4 mL of an aqueous solution of Co(CH3COO)2·4H2O (121.4 mg, 0.49 
mmol) were added dropwise. The mixture was stirred for 10 min and then the formation 
of nanoparticles was induced by fast addition of 100 mL of miliQ H2O. Ligand excess 
was removed by centrifugation and the nanoparticles were washed with a mixture of 
EtOH:H2O (v/v 1:5) until no red fluorescence was observed from the supernatant 
solution. 
Synthesis of M2. To a solution of 2 (3.1 mg, 5.1 µmol), di-tert-buthylcathecol (120 mg, 
0.53 mmol) and 1,4-bis(imidazol-1-ylmethyl)benzene (65 mg, 0.27 mmol) in EtOH (10 
mL), 2 mL of an aqueous solution of Co(CH3COO)2·4H2O (68.9 mg, 0.28 mmol) were 
added dropwise. The mixture was stirred for 10 min and then the formation of the 
nanoparticles was induced by fast addition of 50 mL of miliQ H2O. Ligand excess was 
removed by centrifugation and the nanoparticles were washed with a mixture of 
EtOH:H2O (v/v 1:5) until no red fluorescence was observed from the supernatant 
solution. 
Guest release experiments. A dialysis bag (cut-off molecular weight: 3500) containing 
M1 or M2 (c ~ 3 mg/mL) dispersed in phosphate buffered saline solution (PBS; pH = 
7.4) was placed in 150 mL of PBS (pH = 7.4; dialysate) at 37 ºC under light stirring. To 
determine the increase of 1 or 2 concentration diffused through the dialysis bag, 0.5 mL 
of external PBS solution were taken from the dialysate at prefixed times and diluted in 2 
mL of MeOH, and each aliquot was analyzed by fluorescence spectroscopy. The solid 
material remaining in the dialysis bag after 100 hours was dissolved in methanol and 
characterised by absorption spectroscopy. 
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